Navigation Links
Scripps Florida scientists develop a process to disrupt hepatitis C virion production
Date:3/21/2008

sful.

Before more effective therapies can be developed, scientists need to understand, at the molecular level, the detailed mechanisms HCV uses to infect cells, replicate itself, assemble progeny virus, and exit the cell. Each of these processes could potentially be a target for a new drug to eliminate HCV infection. HCV, like all viruses, requires the normal cellular machinery for its replication and has developed strategies to utilize normal cell physiology for its own benefit (often to the detriment of the host).

The Tellinghuisen team, which includes Research Assistants Katie L. Foss and Jason Treadaway, has focused recent efforts on NS5A to understand the regulation of events used by the virus to assemble infectious copies of itself and exit the cell. NS5A is a three-domain protein, which means it is comprised of three compactly folded regions roughly 50 to 300 amino acids in length. The requirement of domains I and II for RNA replication is well documented. NS5A domain III, however, is not required for RNA replication, and the function of this region in the HCV life cycle is unknown.

Using standard molecular biology, the researchers removed from domain III of NS5A a coding sequence corresponding to roughly 15 amino acids. Then they generated a clone of the virus, transcribed the RNA from that clone, and purified the RNA. This RNA, which is directly infectious, was then transfected into a liver cell line where it produced all the HCV proteins that are encoded by that RNA genome.

Those proteins assemble in the cell to make a structure called a replicase that then copies the viral RNA, Tellinghuisen explains. We measured that RNA accumulation and observed no defect in RNA replication, but found, surprisingly, that no infectious viral particles were released from the cells. The team also found that no viral RNA nor nucleocapsid protein are released from cells, indicating that an early event in virus assembly had been affected.
'/>"/>

Contact: Keith McKeown
kmckeown@scrpps.edu
858-784-8134
Scripps Research Institute
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Scripps Research scientists shed new light on how antibodies fight HIV
2. Scripps Health Treats More Than 160 Fire Victims at Emergency Departments Across San Diego County
3. Scripps research scientists discover chemical triggers for aggression in mice
4. Scripps research scientists find new genetic mutation that halts the development of lupus
5. Scripps scientists find calcium channel blockers help normalize lysosomal storage disease cells
6. Scripps scientists peg wind as the force behind fish booms and busts
7. Scripps research scientists devise approach that stops HIV at earliest stage of infection
8. Scripps Florida awarded $7.6 million grant to develop novel treatment for Parkinsons disease
9. Scripps research team wins $4M grant to study effects of chronic marijuana use
10. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
11. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Dennis Thompson HealthDay ... -- A combination drug therapy aimed at opening the ... treatment for older adults with chronic obstructive pulmonary disease ... COPD patients who received a combination of ... to die or require hospitalization because of their breathing ...
(Date:9/16/2014)... Florida (PRWEB) September 16, 2014 Novatus, ... opened a new office in London, UK, and appointed ... accounts in Europe, the expansion will allow Novatus to ... of its European customers. , “Novatus ... market, and London is an ideal location to establish ...
(Date:9/16/2014)... One in five American men admits to using ... survey shows. A nationally representative study from ... is more prevalent than diabetes. This violence includes ... hitting, kicking, biting, choking, burning or threatening their ... Although abuse by high-profile professional athletes has recently ...
(Date:9/16/2014)... Boston University School of Medicine researcher Dr. Jeffrey ... University were recently awarded a five year, $5 ... Abuse for their project titled: Improving Physician Opioid ... Prescription opioids are the second most commonly abused ... deaths related to prescription opioids now exceed deaths ...
(Date:9/16/2014)... London, UK (PRWEB) September 16, 2014 ... paediatric clinical trials has risen considerably in line with ... USA, over 350 product labels include novel paediatric information ... safety review. In the European countries, there has been ... medicinal products from the submission of old or new ...
Breaking Medicine News(10 mins):Health News:Combo Therapy Best for COPD: Study 2Health News:Combo Therapy Best for COPD: Study 3Health News:Novatus Expands European Operations with a New Office in London 2Health News:1 in 5 U.S. Men Admits to Violence Against Spouse, Partner 2Health News:Paediatric Drug Development Market Analysed by CBR Pharma Insights in In-demand Report Available at MarketPublishers.com 2Health News:Paediatric Drug Development Market Analysed by CBR Pharma Insights in In-demand Report Available at MarketPublishers.com 3
... Less Than One in Five Employers Offer Stand Alone Vision ... VSP(R) Vision Care launched the industry,s first ... it grow to more than 25,000 members nationwide. In a ... economy on health and vision care priorities and costs, VSP ...
... Company,s Portable 4.5kg "Lab in a Box" Allows for Rapid ... 9 DxNA announced today that it has submitted a ... its GeneSTAT(R) pathogen platform, for the detection of the H1N1 ... early availability of important diagnostic and therapeutics tools to diagnose, ...
... GeoFitness,s main goal has been to get Americans up ... and curriculum. Their ability to provide solutions to the ... has provided unprecedented growth. The name change to GeoMotion ... include 3 distinct product lines which can interact to offer ...
... , The Rx.com Electronic Pharmacy Record (EPR) to Integrate ... June 9 PDX and Rx.com have entered into ... which Rx.com manages for multiple chain and independent pharmacy ... single site with aggregated prescription data. The agreement enables ...
... NEW YORK, June 9 United Spinal Association ( ... Island ( www.IndependenceExpo.org ) , the region,s ... for individuals with disabilities and aging Americans. , ... 27th & Sunday, June 28th at the Suffolk Community College ...
... proprietary NeuroTrans(TM) technology , , NOVATO, Calif., June ... (OTC Bulletin Board: RPTP), today announced that it has ... (SWX: ROG.VX; RO.S, OTCQX: RHHBY) to evaluate therapeutic ... proprietary NeuroTrans(TM) BBB transporter platform. Under terms of the ...
Cached Medicine News:Health News:VSP's Individual Plan Thrives in a Starving Economy 2Health News:VSP's Individual Plan Thrives in a Starving Economy 3Health News:DxNA Submits its Rapid Detection Platform Test for H1N1 to FDA 2Health News:DxNA Submits its Rapid Detection Platform Test for H1N1 to FDA 3Health News:GeoFitness, Inc. is Now GeoMotion Group, an Innovative and Fast Growing Learning and Fitness Company for All Ages 2Health News:PDX-Rx.com Works With Microsoft HealthVault to Make Prescription Data Available to Patients 2Health News:PDX-Rx.com Works With Microsoft HealthVault to Make Prescription Data Available to Patients 3Health News:United Spinal Association Presents The 2009 Independence Expo: Improving Life for the Disabled and the Aging 2Health News:Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier 2Health News:Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier 3Health News:Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier 4Health News:Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier 5
(Date:9/16/2014)... , Sept. 16, 2014  Denovo Biopharma, LLC, ... late-stage oncology drug, from Eli Lilly and Company ... manufacture and commercialize enzastaurin globally, including transfer of ... information. Lilly developed enzastaurin in ... and Phase 3 clinical trials for diffuse large ...
(Date:9/16/2014)... Russia,s pharmaceutical market ... 2020 Strategy provides incentives for local producers to develop ... markets. These trends, however, were affected by recent developments ... and economic sanctions imposed on Russia ... Russia responded to the US and ...
(Date:9/16/2014)...   Evana Automation Specialists , a leading Systems ... systems, recently received a contract to provide a robotic ... Evana solution will help error-proof the process of assembling ... reduce labor. A catheter adapter, connector ... cell. The robot will pick the adapter, connector and ...
Breaking Medicine Technology:Denovo Biopharma Acquires Late-Stage Oncology Drug From lilly For Development As A Personalized Medicine 2Global Medicines for Russia 2Evana Automation to Supply Robotic Assembly Cell to Leading Medical Device Manufacturer 2Evana Automation to Supply Robotic Assembly Cell to Leading Medical Device Manufacturer 3
... CardioGenics Holdings Inc. (CGNH.OB) announced today the transfer ... ultra sensitive magnetic beads for use in diagnostic ... beads business unit, which was previously operated out ... will now be operated exclusively out of Luxspheres, ...
... SAN FRANCISCO, June 22, 2011 Vista Partners ... Pharmaceuticals, Inc. (AMEX: ANX ) ("The Company" ... Ross Silver, Principal Analyst at Vista Partners stated, “ANX has ... that could serve multi-billion dollar markets and one candidate with ...
Cached Medicine Technology:CardioGenics Transfers Magnetic Beads Business Unit Into its Luxspheres Inc. Subsidiary 2CardioGenics Transfers Magnetic Beads Business Unit Into its Luxspheres Inc. Subsidiary 3Vista Partners Initiates Coverage on ADVENTRX Pharmaceuticals, Inc.; Target Price $7.50 2
... dual-monochromator, multi-detection microplate reader with a ... reading capability. Detection modalities include absorbance ... and have optical performance comparable to ... Endpoint, kinetic, spectrum and area-well scanning ...
... of PCR, cDNA and Oligonucleotides The ... for a variety applications that are quantified by ... to handle assays in Microplate formats from ... Cuvettes Independent whether you have ...
... High Throughput Screening (HTS), Analyst HT ... HTS by sharing all the detection ... AD, fluorescence intensity, fluorescence polarization, time-resolved ... seamless integration into robotic environments, including ...
... Designed for Ultra High Throughput ... multimode assay detection performance. Allows for ... from assay development by sharing all ... and HT, fluorescence intensity, fluorescence polarization, ...
Medicine Products: